Long-term preservation of biological samples is essential for reproducible research and future clinical use. Cryopreservation and biobanking support the continuity of regenerative medicine by storing viable cells, tissues, and bioengineered constructs without compromising their functionality. Innovations in cryoprotectants, controlled-rate freezing, and vitrification techniques now allow higher post-thaw survival rates and functionality of stem cells and engineered tissues. These advances are crucial for ensuring the availability of genetically matched materials for transplantation and personalized therapies. Cryopreservation and biobanking also play a central role in multi-center trials and biorepositories, enabling the sharing of standardized, quality-controlled samples. As demand increases for diverse and ethically sourced biospecimens, robust biobanking practices become a cornerstone of translational success in tissue engineering and regenerative medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States